Tyler Jacks

Last updated
Tyler Jacks
Alma mater Harvard University
University of California, San Francisco
Scientific career
Fields Cancer Research
Institutions David H. Koch Institute for Integrative Cancer Research
Massachusetts Institute of Technology
Academic advisors Robert Weinberg

Tyler Jacks is a David H. Koch Professor of Biology at the Massachusetts Institute of Technology (MIT), a long-time HHMI investigator, and Founding Director of the David H. Koch Institute for Integrative Cancer Research, which brings together biologists and engineers to improve detection, diagnosis, and treatment of cancer. [1] Dr. Jacks is a member of the board of directors of Thermo Fisher Scientific and Amgen, two of the major biotechnology corporations in the world. [2] [3] He is the President of Break Through Cancer and a member of the Board of Overseers, the larger of two governing boards of Harvard University. [4]

Contents

Early life

Tyler Jacks graduated magna cum laude with Highest Honors in biology from Harvard University in 1983 [5] and earned a PhD in biochemistry from the University of California, San Francisco in 1988 under the guidance of Nobel Laureate Harold Varmus. [6] He then went on to do postdoctoral research at MIT in the Whitehead Institute in the lab of Robert Weinberg. [7]

Career

He was named an Assistant Professor at MIT in 1992 and Associate Professor with tenure in 1997. In 2000, he was promoted to full Professor standing. [8] He has taught the spring version of introductory biology (7.013) at MIT with Professor Hazel Sive and currently teaches The Hallmarks of Cancer (7.45) at MIT with Professor Matthew Vander Heiden.

He served on the Board of Scientific Advisors of the National Cancer Institute and is a past president of the American Association for Cancer Research. [9] He also sits on the board of directors at Thermo Fisher Scientific, Inc. [10] and Aveo Pharmaceuticals Inc. [11] He is a member of the Scientific Advisory Board at T2Biosystems, Inc. and at Epizyme, Inc. [12] He was a founding co-editor of the Annual Review of Cancer Biology in 2017, [13] serving until 2021. [14]

He is the President of Break Through Cancer, a foundation dedicated to supporting multi-institutional teams of researchers focused on finding solutions to some of the most difficult to treat cancers. [15]

Research

He has pioneered the use of gene-targeting technology in mice to study cancer-associated genes and to construct mouse models of many human cancer types. [16] The Jacks lab studies the genetic events that lead to the development of cancer. The lab focuses on using a series of mouse strains carrying engineered mutations known to be involved in human cancer. Through loss-of-function and gain-of-function mutations in tumor suppressor genes as well as the K-ras oncogene, mouse models of many types of cancer have been constructed, including pancreatic cancer, astrocytoma, endometrioid ovarian cancer, colorectal cancer, sarcoma, retinoblastoma, and tumors of the peripheral nervous system. [17]

Awards and recognitions

In 1997, he received the Rhoads Award from the American Association for Cancer Research. [18] In 1998, he won the Amgen Award from the American Society for Biochemistry and Molecular Biology. [19] He has also been named a Ludwig Research Scholar in Cancer Biology from Johns Hopkins University. In 2002, he won the Chestnut Hill Award for Excellence in Medical Research, and in 2005 he won the Paul Marks Prize for Cancer Research. He was elected to the National Academy of Sciences in 2009. [20] In 2014, he was presented the Hope Funds for Cancer Research Award of Excellence for Basic Research.

Related Research Articles

<span class="mw-page-title-main">David Baltimore</span> American biologist (born 1938)

David Baltimore is an American biologist, university administrator, and 1975 Nobel laureate in Physiology or Medicine. He is a professor of biology at the California Institute of Technology (Caltech), where he served as president from 1997 to 2006. He founded the Whitehead Institute and directed it from 1982 to 1990. In 2008, he served as president of the American Association for the Advancement of Science in 2008.

<span class="mw-page-title-main">Harold E. Varmus</span> American scientist (born 1939)

Harold Eliot Varmus is an American Nobel Prize-winning scientist. He is currently the Lewis Thomas University Professor of Medicine at Weill Cornell Medicine and a senior associate at the New York Genome Center.

<span class="mw-page-title-main">Phillip Allen Sharp</span> American geneticist and molecular biologist

Phillip Allen Sharp is an American geneticist and molecular biologist who co-discovered RNA splicing. He shared the 1993 Nobel Prize in Physiology or Medicine with Richard J. Roberts for "the discovery that genes in eukaryotes are not contiguous strings but contain introns, and that the splicing of messenger RNA to delete those introns can occur in different ways, yielding different proteins from the same DNA sequence". He has been selected to receive the 2015 Othmer Gold Medal.

Robert Allan Weinberg is a biologist, Daniel K. Ludwig Professor for Cancer Research at Massachusetts Institute of Technology (MIT), director of the Ludwig Center of the MIT, and American Cancer Society Research Professor. His research is in the area of oncogenes and the genetic basis of human cancer.

<span class="mw-page-title-main">Rudolf Jaenisch</span> German biologist

Rudolf Jaenisch is a Professor of Biology at MIT and a founding member of the Whitehead Institute for Biomedical Research. He is a pioneer of transgenic science, in which an animal’s genetic makeup is altered. Jaenisch has focused on creating genetically modified mice to study cancer, epigenetic reprogramming and neurological diseases.

Sir David Philip Lane is a British immunologist, molecular biologist and cancer researcher. He is currently working in the Department of Microbiology, Tumor and Cell Biology at the Karolinska Institute and is Chairman of Chugai Pharmabody. He is best known for the discovery of p53, one of the most important tumour suppressor genes.

<span class="mw-page-title-main">Nancy Hopkins (scientist)</span> American molecular biologist

Nancy Hopkins, an American molecular biologist, is the Amgen, Inc. Professor of Biology at the Massachusetts Institute of Technology. She is a member of the National Academy of Sciences, the Institute of Medicine of the National Academy, and the American Academy of Arts and Sciences. She is known for her research identifying genes required for zebrafish development, and for her earlier research on gene expression in the bacterial virus lambda, and on mouse RNA tumor viruses. She is also known for her work promoting equality of opportunity for women scientists in academia.

<span class="mw-page-title-main">Lloyd J. Old</span> 20th-century American immunology researcher

Lloyd John Old was one of the founders and standard-bearers of the field of cancer immunology. When Old began his career in 1958, tumor immunology was in its infancy. Today, cancer immunotherapies are emerging as a significant advance in cancer therapy.

<span class="mw-page-title-main">Koch Institute for Integrative Cancer Research</span> MIT cancer research center

The Koch Institute for Integrative Cancer Research at MIT is a cancer research center affiliated with the Massachusetts Institute of Technology (MIT) located in Cambridge, Massachusetts, United States. The institute is one of seven National Cancer Institute-designated basic laboratory cancer centers in the United States.

<span class="mw-page-title-main">Angelika Amon</span> Austrian American academic molecular and cell biologist (1967–2020)

Angelika Amon was an Austrian American molecular and cell biologist, and the Kathleen and Curtis Marble Professor in Cancer Research at the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts, United States. Amon's research centered on how chromosomes are regulated, duplicated, and partitioned in the cell cycle. Amon was elected to the American Academy of Arts and Sciences in 2017.

<span class="mw-page-title-main">Beatrice Mintz</span> American biologist (1921–2022)

Beatrice Mintz was an American embryologist who contributed to the understanding of genetic modification, cellular differentiation, and cancer, particularly melanoma. Mintz was a pioneer of genetic engineering techniques and was among the first scientists to generate both chimeric and transgenic mammals.

<span class="mw-page-title-main">Michael Hemann</span> American cancer geneticist and associate professor

Michael Timotee Hemann is an American cancer geneticist and Professor of Biology in the David H. Koch Institute for Integrated Cancer Research at the Massachusetts Institute of Technology. The research in Hemann's laboratory focuses on identification and characterization of genes involved in tumor formation, cancer progression, and chemotherapeutic response.

<span class="mw-page-title-main">Joan Massagué</span> Spanish biologist

Joan Massagué, is a Spanish biologist and the current director of the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center. He is also an internationally recognized leader in the study of both cancer metastasis and growth factors that regulate cell behavior, as well as a professor at the Weill Cornell Graduate School of Medical Sciences.

<span class="mw-page-title-main">Leona D. Samson</span> Biological engineer (born 1952)

Leona D. Samson is the Uncas and Helen Whitaker Professor and American Cancer Society Research Professor of Biological Engineering at the Massachusetts Institute of Technology, where she served as the Director of the Center for Environmental Health Sciences from 2001 to 2012. Before her professorship at MIT, she held a professorship at the Harvard School of Public Health. She is on the editorial board of the journal DNA Repair. Her research interests focus on "methods for measuring DNA repair capacity (DRC) in human cells", research the National Institute of Health recognized as pioneering in her field, for which the NIH granted her the National Institutes of Health Director's Pioneer Award.

Ed Harlow is an American molecular biologist.

David Arthur Tuveson is an American cancer biologist and is currently Roy J. Zuckerberg Professor of Cancer Research as well as The Cancer Center Director at Cold Spring Harbor Laboratory. Dr. Tuveson is also the Chief Scientist for the Lustgarten Foundation for Pancreatic Cancer Research. He is known for developing some of the first mouse models of pancreatic cancer and more recently, for his work developing pancreatic cancer organoids.

Luis F. Parada is a Colombian developmental biologist and neuroscientist who currently serves as Director of the Brain Tumor Center, Albert C. Foster Chair and American Cancer Society Research Professor at Memorial Sloan Kettering Cancer Center in New York City, New York.

<span class="mw-page-title-main">J. William Harbour</span> American ophthalmologist and researcher

J. William Harbour is an American ophthalmologist, ocular oncologist and cancer researcher. He is Chair of the Department of Ophthalmology at the University of Texas Southwestern Medical Center in Dallas. He previously served as the vice chair and director of ocular oncology at the Bascom Palmer Eye Institute and associate director for basic science at the Sylvester Comprehensive Cancer Center of the University of Miami's Miller School of Medicine.

<span class="mw-page-title-main">Scott W. Lowe</span> American geneticist

Scott William Lowe is Chair of the Cancer Biology and Genetics Program in the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center. He is recognized for his research on the tumor suppressor gene, p53, which is mutated in nearly half of cancers.

Jacqueline A. Lees is a British biochemist.

References

  1. ↑ "Boston.com: Local breaking news, sports, weather, and things to do".
  2. ↑ "Thermo Fisher Scientific Inc. - Investors - Governance - Board of Directors - Person Details".
  3. ↑ "Tyler Jacks".
  4. ↑ "Board of Overseers".
  5. ↑ "Tyler Jacks, Director, Aveo Pharmaceuticals Inc".
  6. ↑ "Tyler Jacks".
  7. ↑ Schroeder, Bendta (26 October 2020). "Tyler Jacks, founding director of MIT's Koch Institute, to step down". MIT Department of Biology. Retrieved 20 May 2024.
  8. ↑ "20 faculty members promoted to full professor". 10 May 2000.
  9. ↑ American Association for Cancer Research Archived 2011-09-30 at the Wayback Machine
  10. ↑ Forbes: Tyler Jacks
  11. ↑ Spoke: Tyler Jacks
  12. ↑ "Stocks". Archived from the original on September 30, 2012.
  13. ↑ Jacks, Tyler; Sawyers, Charles (2017). "Introduction". Annual Review of Cancer Biology. 1: i. doi: 10.1146/annurev-ca-01-121516-100001 .
  14. ↑ "Annual Review of Cancer Biology Editorial Committee". Annual Reviews. 2022. Retrieved 18 July 2022.
  15. ↑ Flannery, Russell (8 August 2022). "Break Through Barriers To Drive Progress: Cancer Moonshot Pathways". Forbes. Retrieved 21 May 2024.
  16. ↑ Spoke: Tyler Jacks
  17. ↑ "Tyler Jacks".
  18. ↑ "Awards & Honors". MIT News | Massachusetts Institute of Technology. 12 March 1997. Retrieved 21 May 2024.
  19. ↑ "Awards and Honors". MIT News | Massachusetts Institute of Technology. 25 February 1998. Retrieved 21 May 2024.
  20. ↑ MIT: NAS Members

Publications

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.